What caused the pre-market move in BRN.AX stock today?

The pre-market jump in BRN.AX stock followed BrainChip’s announced strategic collaboration with ForwardEdge ASIC (Lockheed Martin unit) to embed Akida neuromorphic IP into custom ASICs for RF and signal processing, announced 18 Mar 2026.

How does Meyka AI view BRN.AX stock and what is the short-term forecast?

Meyka AI rates BRN.AX **68.94/100** (Grade B, HOLD). Meyka AI's forecast model projects **A$0.136** in 12 months, implying about **-6.25%** from the current **A$0.145**. Forecasts are projections, not guarantees.

What are the main financial risks for BRN.AX stock investors?

Key financial risks for BRN.AX stock include a small revenue base (**A$2.83M** last 12 months), ongoing losses (**A$30.69M**), high price-to-sales (~**123.25**), and potential share dilution as development requires capital.

What upside scenarios could lift BRN.AX stock?

Upside for BRN.AX stock relies on converting strategic partnerships into recurring revenue, successful Akida ASIC integrations, and repeatable defense or industrial design wins that expand margins and justify higher multiples.

AU Stocks

BRN.AX stock A$0.145 +11.54% pre-market 19 Mar 2026: Lockheed-linked deal

ByDanny Kontos March 18, 2026March 18, 2026

BrainChip Holdings Ltd (BRN.AX) trades at A$0.145, up 11.54% pre-market on 19 Mar 2026 after a strategic collaboration announcement with ForwardEdge ASIC, a Lockheed Martin unit. This move drove 9,553,345 shares to trade and pushed the stock above the day’s low of A$0.135. Investors in BRN.AX stock are watching whether the defence and RF signal-processing opportunity translates into revenue or further strategic wins.